WO1988008448A2 - Cell culture processes, materials and products - Google Patents

Cell culture processes, materials and products Download PDF

Info

Publication number
WO1988008448A2
WO1988008448A2 PCT/EP1988/000362 EP8800362W WO8808448A2 WO 1988008448 A2 WO1988008448 A2 WO 1988008448A2 EP 8800362 W EP8800362 W EP 8800362W WO 8808448 A2 WO8808448 A2 WO 8808448A2
Authority
WO
WIPO (PCT)
Prior art keywords
cells
gel
polymer
process according
growth
Prior art date
Application number
PCT/EP1988/000362
Other languages
French (fr)
Other versions
WO1988008448A3 (en
Inventor
Michael Bay
Original Assignee
Michael Bay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878709499A external-priority patent/GB8709499D0/en
Priority claimed from GB878711044A external-priority patent/GB8711044D0/en
Application filed by Michael Bay filed Critical Michael Bay
Publication of WO1988008448A2 publication Critical patent/WO1988008448A2/en
Publication of WO1988008448A3 publication Critical patent/WO1988008448A3/en
Priority to DK521989A priority Critical patent/DK521989A/en
Priority to FI894998A priority patent/FI894998A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629Keratinocytes; Whole skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/10Hair or skin implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/30Synthetic polymers

Abstract

A new process for culturing anchorage dependent mammalian cells comprises growing the cells in the presence of an aqueous medium on the surface of a sheet of synthetic polymer gel that is swollen by the aqueous medium. The cells are for instance fibroblasts and/or epithelial cells. The polymer gel usually comprises a copolymer of hydroxyethylacrylate and hydroxyethyl methacrylate. The medium can contain growth factors, for instance epidermal and/or fibroblast growth factor. The product can be used as a wound dressing, especially for use as a skin replacement for instance in burn treatment.

Description


  
 



   CELL CULTURE PROCESSES, MATERIALS AND PRODUCTS
 The present invention relates to processes for culturing mammalian cells, particularly epithelial cells, on a substrate and to products of the process, in particular to the use of such products as wound dressings.



   Most normal mammalian cells that are derived from solid organs are anchorage-dependent; that is, they are   substantially    incapable of proliferating in suspended liquid culture but can be made to proliferate on the surface of a substrate which is in contact with growth medium containing the cells.



   Epithelial cells are anchorage dependent. Cells cultured in the presence of a surface will attach to the surface and will multiply in stratified colonies which eventually become confluent. At that. stage the culture enters a steady state in which   di > iding    cells proliferate in the basal layer and the upper cells are shed from the surface, i.e. differentiation takes place and the culture   behaves    to some extent like intact skin. Cell cultures of this type are useful for investigating skin growth, differentiation of skin cells and how it can be controlled as well as   providing    sheets which can be used to graft onto skin as a permanent   coverage    of wounds.



  Holbrook and   winnings      (lit.    Invest. Dermatd. 81; 115-245, 1983) review the vitro growth of epidermal cells.



   The ability of anchorage dependent cells to   proliferate    depends on the substrate surface, as well as the components of the liquid growth medium and the culturing conditions. The properties of the surface which allow adhesion and proliferation of the cells are as yet incompletely understood. Usually culturing is carried out in solid vessels, for instance petri dishes or flasks,  made of glass or, more usually hard transparent plastics material such as polystyrene, and mammalian cells are in general adequately adherent to such surfaces to enable proliferation to occur.



   In many instances it is desired to culture cells and then remove some or all of the cells, sometimes without disrupting the layer that has grown, to another location.



  This may be required when samples are required to be investigated for their properties each by being submitted to different tests or to microscopys for instance in many biopsies. Layers of epithelial cells or   ibroblasts    may be required for use as a skin graft for use in burn treatment or other wound healing.



   Studies have been carried out to investigate the properties of surfaces required for cell adhesion, usually as a means for determining the factors necessary for cell surface attraction and cell adhesion. For instance in Applied Biochemistry and Fiotechnology 8 115-126 (1983) Yoshii et al describe the cell culture of glial cells,   pituitany    tumour cells and a liver cell-in-cell line. The cells were cultured in flasks which had been coated with   polymer    by casting a solution of various types of acrylate ester monomers to form a coating on the inner surface of the flasks and initiating polymerisation. The polymers were swellable to a small amount, the maximum water content of a gel swollen in pure water being 25% by weight. As the polymer is coated onto the culture vessel surface adherent cells cannot easily be removed from the vessel.



   Other techniques of culturing   anchoragewdependent    cells involve coating of the hard culture surfaces with molecules found in the extra-cellular matrix of the cells in their normal surroundings, for example using various collagens, fibronectin or laminin. In J. Cellular
Physiology 83, 379-379 (1973) Macieira-Coelho cultivate  fibroblasts in vessels having a coating of polymeric bovine serum albumin covered with charged materials such as   polyiamino    acids) histones and heparin. Although these may facilitate the growth of the cells, the methods still have the disadvantages mentioned above of growth on hard surfaces.



   In Experimental Cell Research 143, p. 15-25 (1983)
Faris et al describe the cultivation of endothelial cells and fibroblasts is carried out on the surface of sheets of poly(hydroxyethyl meth-acrylate) (HEMA) in culture medium. The polymer is optionally prepared in the presence of protein, for instance collagen or   e-lastin.   



  HEMA homopolymer has a limited swellability, being capable of absorbing 0.9% saline to give a gel having a maximum of 38% by weight saline content.



   In Cell (1977) 11, pp 405 to 416, "Terminal
Differentation of Cultured Human Epidermal Cells" by
Green, keratinocytes from the foreskin of new born humans were cultured to form stratified confluent colonies. The culture is used in an investigation of the differentiation. In Experimental Cell Research (1980) 125 pp 141 to 152 "Fine Structure of Sub Cultivated
Stratified Squamous Epithelium" hy   tepsen    et al rat lingual epithelium is cultivated and the primary explants are sub-cultivated on plastic culture flask surfaces to produce long lived cultures. In the   Journal    of
Investigative Dermatology 1987, 88:314-319
Arenholt-Bindslev et al describe experiments in which human oral keratinocytes are cultured and sub-cultured successfully in hard plastics flasks.



   Often, to facilitate the growth and a differentiation of epithelial cells, feeder cells are used. For example, in Green (1977) discussed above, lethally irradiated 3T3 cells are used as feeder cells.



  In Cell (1975) 6 pp 331 to 344 "Serial cultivation of  strains of human epidermal keratinocytes: the formation of keratinising colonies from single cells", Rheinwald et al describe the use of fibroblast cells as feeder cells.



   There have been various disclosures of the use of cultivated epithelial cells as skin grafts. In the
Journal of Trauma (1986) 26 pp 955 to 962 Madden et al describe the use of cultured allogeneic epidermis (i.e.



  derived from a person other than the patient) as a graft on second and third degree burn wounds. Although a consequence of thermal injury is immunosuppression which prevents early rejection of the allograft, these grafts are normally rejected unless drugs are used as immunosuppressents in the long term. Furthermore the use of tissue from other humans involves serious risks of infection, especially viral infection such as by HIV, which it is highly desirable to avoid.



   It is therefore preferred to use autologous cultured epithelium. In the New England Journal of Medicine (1984, 16th August) pp 448 to 451, Gallico et al describe the use of cultured sheets of autologous epithelial cells as skin grafts. In the Lancet (1986) 1 pp 1123 to 1124,
Cuono et al describe the use of an allograft of whole skin as a first stage of the grafting process onto a burn wound and the subsequent replacement of the epidermal layer of the allograft   b    cultivated of autogeneic epidermis on the dermal allograft. This method of grafting was successful since the dermis is found to be less immunoreactive than the epidermis, but the risks of viral infection are still severe.

 

   One of the problems with the use of hard plastics or glass surfaces as the substrate for epithelial cell cultures is that the culture medium is supplied only from above the surface so that the basal cells have poor access to the medium This leads to a slow growth rate since it is the basal cells which are capable of  dividing. A further disadvantage where the cell sheets are to be used as skin grafts is that the sheet, which is not very mechanically strong, must be dislodged from the surface and handled unsupported, which can be inconvenient and can damage the sheet.



   It is known to support the sheet after it has been dislodged from the surface in order to facilitate handling thereafter. For example in Gallico et al (op cit) the sheets are clipped to gauze, and in Cuono et al (op cit) a backing of "N-Terface" was placed on top of the culture. Although these techniques overcome some of the difficulties with handling the sheets, the methods still have the disadvantages associated with growth on hard surfaces as well as still requiring that the sheets be dislodged from the surface. Dislodgment from the hard surface can be facilitated by applying an enzyme such as dispase as disclosed in US4304866.



   Epithelial cells have also been grown on collagen gels and the collagen with the layer of epithelial cells has been used directly as a skin replacement. For example in Proc. Natl.   Acad.    Sci. USA   t1979)    76 pp 1274 to 1276
El et al describe the use of a collagen gel as a substrate for epidermal cells. Human fibroblasts are seeded into the collagen lattices to be used as feeder cells. In the Journal of Investigative Dermatology (1983) 81 pp 2S to   10S,    Bell et al describe the reconstitution of living skin comprising a dermal equivalent made up of fibroblasts in a collagen matrix and an epidermal equivalent   dea7eloped    from keratinocytes "plated" onto the collagen. The skin equivalents have been successfully grafted onto rats.



   Some studies have shown that the growth of epithelial cells at the air/liquid interface, to mimic the in   viSo    conditions, can in some cases lead to improved stratification (differentiation) , when the cells  are grown on collagen gel in comparison to cells which are totally immersed in the liquid medium during culturing.



   Although the epithelial cells grow well on the collagen gel, there are several problems with the use of collagen. It is an expensive material, especially when it is supplied in its isolated form and even then is time consuming to make up as it is supplied as a powder which must be dissolved and gelled. The isolation and creation of the gel from the natural source in the laboratory is time consuming. Furthermore collagen is not well defined since it is a natural substance so that its behaviour from batch to batch may differ, making procedures difficult to standardise. This is particularly undesirable from a clinical point of view when the collagen is to be used as part of a skin graft.

  Collagen is furthermore difficult to work with in the laboratory, one of the problems being that the size of the gel and thus its water content depends upon the presence of other cells particularly fibroblasts, which are used as feeder cells. The size of the gel can vary in use which is clearly disadvantageous when the gel is to be used as part of a skin replacement. When the water content is reduced to below a certain level the gel becomes   opaaue    which makes it less easy to observe the rate of wound healing below a graft comprising the gel. A further problem is that being a protein collagen cannot be sterilised by steam so that during storage it can only be kept free of micro-organisms by the use of antibiotics or by other methods of sterilisation.

  Being a natural substance collagen gel is in any case a good substrate for the growth of undesirable micro-organisms and its use on wounds can then encourage infection. A yet further disadvantage is that when the gel with the epithelial cell culture is used as a skin replacement, a further  barrier is required directly on top of the epithelial cell culture.



   According to the invention there is provided a new process in which anchorage dependent mammalian cells are cultured in the presence of an aqueous culture medium on the surface of a removable substrate which is a gel comprising a water-insoluble, water-swellable hydrophilic synthetic polymer swollen with the medium, and the process is characterised in that   tikle    polymer has a swellability such that it can absorb at least its own dry weight of   0.98    by weight saline.



   The process is of particular use in the culturing of human cells, preferably epithelial cells and fibroblasts, although the use of the polymer substate is also advantageous for the culture of a wide range of mammalian anchorage dependent cells.



   In the new process in which the cells on the surface may be exposed to the gaseous medium above the aqueous medium during a part at least of the culturing process.



  The cells may be exposed for a period early or late in the culturing process, or throughout the process.



   Throughout the culturing process the synthetic polymer gel is swollen with aqueous medium, so that nutrients are supplied to the cells   V-ia    the gel substrate. Any exposure of the cells to gaseous medium during the process is achieved by maintaining the surface on which the cells are growing in contact with the surrounding air or other gaseous medium while at the same time supplying aqueous medium continuously to the gel.



   For instance the gel can be partially immersed in the aqueous medium, e.g. by supporting it at the surface using solid supports or by allowing the gel to float on the surface of the aqueous medium.



   This process may be useful as a research tool to investigate the growth and differentiation of epithelial  cells in vitro by mimicking the in vivo conditions in which the surface layer of skin is exposed to the atmosphere, nutrients being supplied from underneath the skin.



   Apart from the use of the special substrate the cell culture is conventional containing the usual nutrients and components for controlling the rate of growth. Thus for epithelial cells the culture medium may contain substances known to facilitate the growth of epithelial cells. These may be growth factors, for example epidermal growth factor (EGF), usually combined with substances derived from feeder cells, for example normal human fibroblasts, 3T3 cells or glial or other brain cells.



   In a preferred process feeder cells are grown on the surface of the container for the culture medium and, when they have established their growth the epithelial cells are introduced. A swollen synthetic polymer gel may be introduced onto the established feeder cell layer. This may allow the growth of epithelial cells in the presence of, but physically separated from, feeder-cells.

 

  Alternatively feeder cells may be grown   or.    a surface of swollen synthetic polymer gel   andr    after the growth has been established, the epithelial cells are introduced.



  Sometimes epithelial cells are grown   6n    the same surface as feeder cells but, as indicated, different cells types can be grown on different surfaces. When the feeder cells are fibroblasts these can be treated to prevent them multiplying as described by Green in US4C16036.



  Furthermore the cells can be grown by the procedure described in   FR2589165    where the culturing comprises two steps between which the cells are frozen, the second step being carried out in accordance with the present invention
 The culture medium may contain any of the conventional components well known to those skilled in  the art, for instances as described in any of the above-mentioned publications. Thus the culture medium may contain other growth-affecting substances, serum, nutrients, enzymes, sequestrants, buffers and/or antibiotics or other conventional substances. The substrate may have proteing or other natural substances incorporated into it or cOated onto it, to affect the growth of the cells, for instance protein such as elastin or collagen.

  Such components can, as disclosed by Faris et al   (op    cit), allow selection of particular types of cells for growth.



   The polymer gel used in the process is preferably wholly synthetic. It is generally in the form of a swollen sheet, for example 0.1 to 5mm thick preferably 0.5 to 2mm thick.



   In order for the polymer to be sufficiently permeable to nutrients and water it should have a swellability such that it can absorb at least its own weight of   0.9%    by weight saline, that is, it swells in   0.98    saline to give a gel which comprises at least 50% by weight saline. Usually the polymer can absorb   0.9e    saline to give a gel which comprises more than   609    saline preferably 70 to   959    saline. The polymer from which the substate is formed is often such that it will absorb up to 100 times its dry weight of water.

  Since the aqueous culture will contain dissolved substances, for example any of those mentioned above, the swellability of the polymer in that medium is likely to be lower than in pure water the swellability usually being about the same as in 0.9% saline. Preferably the polymer is capable of absorbing the aqueous medium in an amount in the range 1 to 50 times of its own dry weight, preferably 1.5, more preferably 2, or 3 to 20 times its own weight, for example about 10 times its weight in the aqueous medium.



  The swellability of the polymer is as high as possible in  order to improve the permeability of the polymer to oxygen and to substances required for epithelial cell growth. Preferably the gas permeability of the polymers substrate is such that it has a DK value of at least 20, preferably in the range 20 to 35. Gels with high swellability also allow quicker equilibration of the liquid phase within the gel and the liquid medium when the gel is first introduced into the medium and this is advantageous for cell growth.



   The polymer is preferably formed from ethylenically unsaturated monomer, preferably comprising acrylic monomer The monomer most preferably comprises a hydroxy alkyl   (meth)    acrylate, for example selected from those in which the alkyl group has 2 to 4 carbon atoms. Examples of such monomers are hydroxyethyl acrylate (HEA), hydroxyethyl methacrylate (HEMA) hydroxypropyl methacrylate, hydroxypropyl acrylate and hydroxytrimethylene acrylate. The monomer   preferablxz    comprises HEA and/or HEMA. Such hydroxy alkyl (meth) acrylates and generally co-polymerised with one or more co-monomers which may be hydrophilic or   hydrophohic    and which are selected to impart specific chemical or physical properties to the resulting co-polymer.

  Examples of co-monomers are alkyl   (meth)    acrylates alkoxy alkyl   (meth)    acrylates, polyalkylene glycol (meth) acrylates, (meth) acrylic acid, (meth) acrylamide, styrene, N-vinyl lactam, e.g. N-vinyl pyrrolidone.   Tncorporation    of   hvdrophilic    monomer, e.g. (meth) acrylic acid, in general increases the swellability of the polymer.



   The preferred polymers are formed from a major amount, i.e. 50 to 100%, of hydroxy alkyl (meth) acrylate, with a minor amount, i.e. 50 to   02    of a co-monomer. The most preferred mixture comprises 50 to 100%, preferably 75 to   99,    more preferably 90 to 98%  
HEMA and/or HEA with minor amounts of co-monomer, preferably a hydrophilic co-monomer.



   The polymer is preferably cross-linked, cross-linking rendering it insoluble, controlling the swellability and giving it physical strength.



  Cross-linking is preferably covalent and is generally achieved by incorporating into the polymerisation mixture of di- or poly-functional ethylenically unsaturated compounds in appropriate amounts, generally less than 2% by weight of the monomer mixture for example in amounts in the range   .0.01    to 2%, preferably .05 to   1.5t,    generally in the range .05 to 1%. Examples of cross-linking agents of this type are well known in the art and may include di- or tri-esters of (meth) acrylic acid, for example alkylene di- (meth) acrylates, generally in which the alkylene has from 2 to 4 carbon atoms, or di- or poly-alkylene glycol (meth) acrylates, generally in which the alkylene groups have -2 to 4 carbon atoms, and also alkylene bis (meth) acrylamides, usually methylene bis (meth) acrylamide.



   The polymerisation may be carried out without any diluent or may be carried out in the presence of water or other suitable diluent by known techniques.



  Polymerisation of aqueous solutions of monomers is described in US2976576. Polymerisation in the substantial absence of liquid diluents is described in   US3520949.   



  Polymerisation in the presence of-non-aqueous diluents is described in GE-A-2097805 which describes the polymerisation in the presence of an ester formed from boric acid and a compound containing 3 or more hyroxyl groups. In EP-A-0182659 polymerisation is carried out in the presence of a range of water-displacable solvents, including ester reaction products of carboxylic acids or anhydrides and polyols, often di-functional carboxylic acids, and polyols themselves and mixtures. Any of the  methods described in those references may be used to form the polymer used in the present invention. Polymerisation may be carried out in the presence of protein or other natural compounds. Proteins may be, for instance, collagen or elastin.



   The polymerisation is initiated by any known means, for example by using thermal initiators, redox initiators and/or maybe initiated using irradiation, optionally including an irradiation-sensitive catalyst. The irradiation may comprise u-v irradiation, electron beam irradiation or irradiation from a radioactive source.



  Curing agents suitable for use with these forms of irradiation are well known in the art.



   Sometimes it may aid adhesion of the cells to render the surface of the gel rough or porous and this may be achieved by including suitable diluents in the polymerisation mixture.



   Although the polymer may be formed into the, desired shape after polymerisation, it is generally polymerised to the desired shape, i.e. as        sheet. The polymerisation mixture is therefore polymerised within a mould or, usually, cast onto a flat surfacer optionally covered with a protective sheet substance and then polymerised.

 

  The layer of mixture may be in the range 0.1 to 2mm, preferably 0.2 and lmm, more preferably about 0.5mm thick.



   Following completion of the polymerisation the polymer must be washed to rid it of any low molecular weight contaminants, which may comprise for instance excess unpolymerised monomer. Since the polymer is to be used in direct contact with cells, it is most important for excess monomer to be washed out of it. Washing can be carried out by any of the known techniques   which    are suitable for this. The washing process may comprise several sequential washes using demineralised water or  using water of different   conductivities    in sequential steps. One suitable process comprises soaking the polymer in successively more conductive water.



   The polymer may be provided in the form of a package and containing polymer as defined above containing also components of the cell culture medium, the contents of the package being suitable for use in the new process.



  The package may contain dried polymer containing any of the substances, preferably,   howesJer,    it comprises polymer in the form of a gel swollen with an aqueous liquid containing any of the components. Thus it may comprise serum, growth-effecting substances, nutrients, enzymes, sequestrants, buffers and/or antibiotics.



   The gel may be provided in a container which is suitable for use directly as a container for the culture medium in the process of the invention. More conveniently however the polymer is provided in a sterile sealed package of a foil, generally a metal or a plastics foil, which is easy to use in the laboratory. The sealed package is preferably sterilised using steam sterilisation whilst   subiecting    the outside of the package to external pressure to prevent it bursting. The pressure may be exerted by holding the package in a mould, but is more   convenient ly    by gas pressure, sterilisation is preferably carried out using an autoclave, preferably one in which the temperature and pressure are independently variable.



   In the invention there is also provided a new product which comprises a gel substrate which comprises a water-insoluble, water-swellable synthetic hydrophilic polymer swollen with an aqueous liquid and having   a    lever of cultured mammalian cells on its surface. The new product is the product of a new process according to the invention, thus the cells are preferably fibroblasts or epithelial cells.  



   One particularly useful application of the product is as a skin graft, for example in animals or humans. In such an application the gel covered by a layer (generally substantially a monolayer) of epithelial or fibroblast cells is placed cell side down upon the wound, for example a burn wound. The gel acts as a barrier in particular to bacteria whilst being   suffbciently    oxygen permeable to allow healing to continue. For further protection and to keep the product in place and to keep the gel moist it is preferred for the dressing to be covered by further coverings. The gel will generally be left in place for several days, until the cells are grafted onto the wound and then the gel may be pealed off and replaced with further swollen gel of the same type, or with conventional wound coverings.

  Nutrients and growth factors, antibiotics, analgesics, anti-inflammatonics etc. may be incorporated in the aqueous liquid with which the gel is swollen, either before application to the patient or after application.



   If a product carrying a layer of fibroblast cells is applied to a wound, the   fihroblasts    may act as feeder cells for the natural epithelial cells present at the site of the wound, stimulating these to multiply and differentiate, thereby healing the wound. The epithelial cells are stimulated to grow under the wound-contacting side of the gel, so that the gel can subsequently be removed from the wound. Because the gel is permeable to nutrients for the epithelial cells these can diffuse to the cells through the gel. Preferably the   fibroblast    culture is developed from the wound of the patient.

  This application is particularly useful since the fibroblasts are relatively easy to culture in vitro and it is not necessary to culture epithelial cells in vitro, as their growth is stimulated in vivo by the cultured   fibroblasts.    This is especially advantageous in view of  the greater difficulty in growing epithelial cells in vitro. For particularly bad burn wounds it may be helpful to seed the wound with epithelial cells or the use of cultured epithelial cells simultaneously with the use of the gel carrying the cultured fibroblasts.



   A product which has a layer of cultured epithelial cells could alternatively be applied to a wound.



   Such a product may be used to replace the sheets of cultured epithelia or skin replacements comprising collagen gel carrying epithelial cell cultures used in any of the methods described in the above mentioned prior art. If necessary the gel can be separated from the adherent cells by the use of dispase, as disclosed by
Green in   US4016036,    either immediately after application to the wound or later.



   The gel used in the present invention has numerous advantages over substrates used in the prior art. It has the advantage over hard surfaces that it is permeable so that nutrients and other components of the culture medium are supplied to basal cells of a culture to provide a more efficient growth. It is much cheaper than collagen and is well defined which is essential for clinical use.



  It is far easier to handle physically and since it is well defined chemically, is easier to standardise and control. Being synthetic it is also a worse substrate for micro-organism cell growth which is advantageous in the process as well as in the final product reducing the risk of bacterial or other infection. The swollen gel is relatively permeable to oxygen so that healing is maintained whilst acting as a barrier to bacteria and other unwanted components. The gel can be sterilised before use using steam sterilisation which is highly advantageous. Furthermore the gel is transparent so that wound healing can be observed through the gel.  



   Use of the products as aids to wound healing can avoid completing the use of foreign tissue and natural substances such as collagen, thus minimising risk of infection and   immunological 'rejection,   
 Another use of the process of the invention is for conducting investigations on the cells themselves particularly where subcultivation is necessary or where a number of different tests need to be carried out on samples of the cultured cells.



   The following examples illustrate the invention:
EXAMPLE
Formation of polymer gel
 97.5 parts HEMA (containing 200 PPM   kiydroquinone    monomethyl ether   HQME)    1 part containing   HEA    (containing 200.PPM HQME) and   0;75    parts methacrylic acid with 0.5 parts a cross-linking monomer comprising ethylene glycol di-methacrylate, were mixed together. 0.25 parts of a curing agent (Darocur 1173) was added to the polymerisation mixture which was then cast onto a flat surface to a thickness of 0.5mm. The mixture was cured by irradiating with   UV    at a wavelength of 365nm using an intensity of   200mW/cm2    for a period of about 60 minutes.

 

   Following polymerisation the polymer was removed from the surface and was immersed in water having a conductants of 750 microsiemens/cm for about 12 hours.



  The polymer gel was then placed in water having a conductants of 1550 microsiemens/cm2 for a further period of about 12 hours. The polymer was then immersed in a 0.9% sodium chloride solution in redistilled water for several hours. Pieces of the gel sheet were then packed in   polypropylene    foil containers containing excess impregnant sodium chloride solution. The pouches were  heat sealed and were then sterilised in an autoclave at a temperature of 1210C for a period of 15-20 minutes.



   The polymer produced by this process was capable of absorbing 0.9% saline to form a gel having 70% by weight impregnant liquid.



  Use as culture substrate
 Sheets of polymer hydrogel produced as described above were incubated in sterile MEM (Minimal Essential
Medium) at 34 degrees centigrade for a period of 3 days before the experiment. The gaseous   ensrironment    consisted of 5 percent   CO2    in air.



   The polymer sheets were cut into 1 sq cm pieces and placed in culture flasks (Nunclon R) and fixed to the surface of the culture flask with a small clot of sterile silicone fat to prevent floating of the polymer sheet.



  Three pieces of gel were placed in each culture flask.



  CELLS a) Cultures of rat palatal epithelial (RPE) cells were established, maintained and subcultivated according to methods previously described in Jepsen et al   (op.    cit).



  Cells in 0 passage were used in the present study.



  b) A transformed tumorigenic cell line derived from the
RPE cell line mentioned above was maintained and subcultivated following the same procedures as for non-tumorigenic RPE cells.



  c) Cultures of normal human oral epithelial cells were established, maintained and   subcultivated    according to methods previously described in Arenholdt-Bindslev et al (op. cit).

 

   Immediately following the introduction of gel fragments into culture flasks, 7.5 ml of cell suspension containing a total of 5 x 106 cells was added to each flask.  



   Each cell type was introduced into two flasks. Cells were left to attach for 4 days. Cell attachment was followed in phase contrast microscope and   hiopsies    taken out and processed for light microscopy on day 6. Photos were taken at day 6.



   After 4 days all three cell types had attached to the surface of the gel fragments. During the following days cell proliferation could be observed on the gels. On day 6 the gels incubated with both tumorigenic and non-tumorigenic rat oral epithelial cells were covered   b    a confluent layer of epithelial cells. The human epithelial cells proliferated but more slowly. 

Claims

1. A process in which anchorage dependent mammalian cells, are cultured in the presence of an aqueous medium on the surface of a removable substrate which is a gel comprising a water-insoluble, water-swellable hydrophilic synthetic polymer swollen with the aqueous medium characterised in that the polymer has a swellability such that it can absorb at least its own weight of 0.9% saline.
2. A process according to claim 1 characterised in that the gel has a swellability such that when swollen in 0.9% saline the gel comprises 70% to 95% by weight of saline.
3. A process according to claim 1 or 2 in which the polymer from which the gel is formed is wholly synthetic.
4. A process according to any preceding claim in which the polymer is formed from ethylenically unsaturated monomer, preferably comprising acrylic monomer.
5. A process according to any preceding claim in which the cells comprise fibrobasts and/or epithelial cells.
6. A process according to claim 5 in which the cells are epithelial cells and in which the culture medium contains one or more substances to facilitate the growth of the epithelial cells, preferabl comprising substances derived from feeder cells.
7. A process according to claim 6 in which the feeder cells comprise brain cells, fibroblasts or 3T3 cells.
8. A process according to any preceding claim in which the culture medium contains components selected from growth-affecting substances, serum, nutrients, enzymes, sequestrants, buffers and antibiotics.
9. A process according to any preceding claim in which the anchorage dependent cells are beneath the surface of the aqueous medium throughout the process.
10. A product comprising a gel comprising water-insoluble, water-swellable synthetic hydrophilic polymer swollen with an aqueous liquid and having a layer of cultured anchorage dependent mammalian cells.
11. A product according to claim 10 in which the gel is in the form of a sheet.
12. A wound-dressing which is a product according to claim 10 or 11 and/or the product of a process according to any of claims 1 to 9.
PCT/EP1988/000362 1987-04-22 1988-04-21 Cell culture processes, materials and products WO1988008448A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK521989A DK521989A (en) 1987-04-22 1989-10-20 PROCEDURE FOR CULTIVATING CELLS AND MATERIALS FOR USE THEREOF
FI894998A FI894998A0 (en) 1987-04-22 1989-10-20 CELLODLINGSPROCESSER, MATERIAL OCH PRODUKTER.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878709499A GB8709499D0 (en) 1987-04-22 1987-04-22 Cell culture processes
GB8709499 1987-04-22
GB8711044 1987-05-11
GB878711044A GB8711044D0 (en) 1987-05-11 1987-05-11 Cell culture

Publications (2)

Publication Number Publication Date
WO1988008448A2 true WO1988008448A2 (en) 1988-11-03
WO1988008448A3 WO1988008448A3 (en) 1988-12-01

Family

ID=26292160

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1988/000362 WO1988008448A2 (en) 1987-04-22 1988-04-21 Cell culture processes, materials and products

Country Status (6)

Country Link
EP (1) EP0355112A1 (en)
JP (1) JPH02504221A (en)
AU (1) AU614747B2 (en)
DK (1) DK521989A (en)
FI (1) FI894998A0 (en)
WO (1) WO1988008448A2 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382214A1 (en) * 1989-02-10 1990-08-16 Kao Corporation Method of cell culture
EP0387975A1 (en) * 1989-03-16 1990-09-19 W.R. Grace & Co.-Conn. Cell culture substrate cell sheet, cell cluster and preparations thereof
EP0396138A2 (en) * 1989-05-04 1990-11-07 Millipore Corporation Method for growing cellular tissue
WO1991013638A1 (en) * 1990-03-05 1991-09-19 Smith & Nephew Plc Cell culture products
EP0455319A2 (en) * 1990-05-02 1991-11-06 W.R. Grace & Co.-Conn. Cytotoxicity test method
EP0470681A2 (en) * 1990-08-08 1992-02-12 W.R. Grace & Co.-Conn. Cell clusters or sheets comprising a plurality of cell species and preparations thereof
US5284766A (en) * 1989-02-10 1994-02-08 Kao Corporation Bed material for cell culture
WO1995032743A1 (en) * 1994-05-31 1995-12-07 Ústav Makromolekulární Chemie Akademie Ved Ceské Republiky Temporary biologically active cover for extensive wound areas and method of preparing thereof
EP0735135A2 (en) * 1995-03-31 1996-10-02 DIZG Deutsches Institüt für Zell- und Gewebeersatz gGmbH Cell sheets and transport system for cell sheets
WO1997006835A1 (en) * 1995-08-12 1997-02-27 Smith & Nephew Plc Cell culture products
US5712137A (en) * 1990-03-05 1998-01-27 Smith & Nephew Plc Laminate of a culture substrate on a carrier for producing an apertured wound dressing
EP0929661A1 (en) * 1995-11-15 1999-07-21 The University Of Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
WO1999064563A1 (en) * 1998-06-10 1999-12-16 Ústav Makromolekulární Chemie Akademie Věd České Republiky Polymer carrier for cultivation of keratinocytes
FR2807765A1 (en) * 2000-04-18 2001-10-19 Cell Culture Ct Comp Production of anchorage-dependent cells, useful e.g. for protein production, and as artificial organs, by growing on cryosensitive two-dimensional supports
US6596532B1 (en) 1997-12-12 2003-07-22 BIOMéRIEUX, INC. Device for isolation and surface culture of microorganisms from bulk fluids
US7358082B2 (en) * 2003-07-16 2008-04-15 Fujifilm Corporation Device and method for culturing cells
WO2009099539A2 (en) * 2008-01-30 2009-08-13 Corning Incorporated (meth)acrylate surfaces for cell culture, methods of making and using the surfaces
WO2009099555A3 (en) * 2008-01-30 2010-01-21 Geron Corporation Synthetic surfaces for culturing cells in chemically defined media
US8241907B2 (en) 2008-01-30 2012-08-14 Geron Corporation Synthetic surfaces for culturing stem cell derived cardiomyocytes
US8513009B2 (en) 2008-01-30 2013-08-20 Geron Corporation Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
TWI550088B (en) * 2014-01-16 2016-09-21 國立台灣大學 Method for rejuvenating aged cells and composition thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621722B2 (en) * 1989-03-16 1992-03-19 W.R. Grace & Co.-Conn. Cell culture substrate, cell sheet, cell cluster and preparations thereof
WO1993003139A1 (en) * 1991-08-08 1993-02-18 Kao Corporation Cell culture support, production thereof, and production of cell cluster using same
US8329469B2 (en) * 2008-01-30 2012-12-11 Geron Corporation Swellable (meth)acrylate surfaces for culturing cells in chemically defined media

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO163060C (en) * 1981-03-13 1990-03-28 Damon Biotech Inc PROCEDURE FOR THE PREPARATION OF SUBSTANCES MADE BY LIVING CELLS PRODUCING INTERFERONES OR ANTIBODIES.
FR2589165B1 (en) * 1985-10-24 1989-01-20 Inst Nat Sante Rech Med PROCESS FOR OBTAINING A HUMAN CULTURE EPITHELIUM, EPITHELIAL FABRIC OBTAINED AND ITS APPLICATION TO ALLOGRAFTS

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382214A1 (en) * 1989-02-10 1990-08-16 Kao Corporation Method of cell culture
US5284766A (en) * 1989-02-10 1994-02-08 Kao Corporation Bed material for cell culture
EP0387975A1 (en) * 1989-03-16 1990-09-19 W.R. Grace & Co.-Conn. Cell culture substrate cell sheet, cell cluster and preparations thereof
EP0396138A2 (en) * 1989-05-04 1990-11-07 Millipore Corporation Method for growing cellular tissue
EP0396138A3 (en) * 1989-05-04 1991-02-06 Millipore Corporation Method for growing cellular tissue
EP0681846A2 (en) 1990-03-05 1995-11-15 Smith & Nephew P.L.C. Cell culture products
WO1991013638A1 (en) * 1990-03-05 1991-09-19 Smith & Nephew Plc Cell culture products
US6039972A (en) * 1990-03-05 2000-03-21 Smith & Nephew Plc Wound dressing containing mammalian cells anchored on hydrophobic synthetic polymer film
US5712137A (en) * 1990-03-05 1998-01-27 Smith & Nephew Plc Laminate of a culture substrate on a carrier for producing an apertured wound dressing
EP0681846A3 (en) * 1990-03-05 1996-03-27 Smith & Nephew Cell culture products.
GB2252562A (en) * 1990-03-05 1992-08-12 Smith & Nephew Cell culture products
GB2252562B (en) * 1990-03-05 1994-04-20 Smith & Nephew Wound dressing comprising cultured cells
EP0455319A3 (en) * 1990-05-02 1993-05-05 W.R. Grace & Co.-Conn. Cytotoxicity test method
EP0455319A2 (en) * 1990-05-02 1991-11-06 W.R. Grace & Co.-Conn. Cytotoxicity test method
EP0470681A3 (en) * 1990-08-08 1992-04-22 W.R. Grace & Co.-Conn. Cell clusters or sheets comprising a plurality of cell species and preparations thereof
EP0470681A2 (en) * 1990-08-08 1992-02-12 W.R. Grace & Co.-Conn. Cell clusters or sheets comprising a plurality of cell species and preparations thereof
WO1995032743A1 (en) * 1994-05-31 1995-12-07 Ústav Makromolekulární Chemie Akademie Ved Ceské Republiky Temporary biologically active cover for extensive wound areas and method of preparing thereof
EP0735135A2 (en) * 1995-03-31 1996-10-02 DIZG Deutsches Institüt für Zell- und Gewebeersatz gGmbH Cell sheets and transport system for cell sheets
EP0735135A3 (en) * 1995-03-31 1997-12-29 DIZG Deutsches Institüt für Zell- und Gewebeersatz gGmbH Cell sheets and transport system for cell sheets
WO1997006835A1 (en) * 1995-08-12 1997-02-27 Smith & Nephew Plc Cell culture products
EP0929661A1 (en) * 1995-11-15 1999-07-21 The University Of Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
EP0929661A4 (en) * 1995-11-15 2000-01-12 Univ Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
US6596532B1 (en) 1997-12-12 2003-07-22 BIOMéRIEUX, INC. Device for isolation and surface culture of microorganisms from bulk fluids
US7183073B2 (en) 1997-12-12 2007-02-27 Biomerieux, Inc. Method for detecting microorganisms
WO1999064563A1 (en) * 1998-06-10 1999-12-16 Ústav Makromolekulární Chemie Akademie Věd České Republiky Polymer carrier for cultivation of keratinocytes
FR2807765A1 (en) * 2000-04-18 2001-10-19 Cell Culture Ct Comp Production of anchorage-dependent cells, useful e.g. for protein production, and as artificial organs, by growing on cryosensitive two-dimensional supports
WO2001079453A1 (en) * 2000-04-18 2001-10-25 4C Biotech Cell culture method, cell cluster obtained by said methods and use thereof
US7358082B2 (en) * 2003-07-16 2008-04-15 Fujifilm Corporation Device and method for culturing cells
WO2009099555A3 (en) * 2008-01-30 2010-01-21 Geron Corporation Synthetic surfaces for culturing cells in chemically defined media
WO2009099539A2 (en) * 2008-01-30 2009-08-13 Corning Incorporated (meth)acrylate surfaces for cell culture, methods of making and using the surfaces
WO2009099539A3 (en) * 2008-01-30 2010-05-27 Corning Incorporated (meth)acrylate surfaces for cell culture, methods of making and using the surfaces
US8241907B2 (en) 2008-01-30 2012-08-14 Geron Corporation Synthetic surfaces for culturing stem cell derived cardiomyocytes
US8513009B2 (en) 2008-01-30 2013-08-20 Geron Corporation Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
CN102159704B (en) * 2008-01-30 2013-12-25 杰龙公司 Synthetic surfaces for culturing cells in chemically defined media
EP2420564A3 (en) * 2008-01-30 2013-12-25 Geron Corporation Synthetic surfaces for culturing cells in chemically defined media
US9745550B2 (en) 2008-01-30 2017-08-29 Asterias Biotherapeutics, Inc. Synthetic surfaces for culturing stem cell derived cardiomyocytes
US10221390B2 (en) 2008-01-30 2019-03-05 Asterias Biotherapeutics, Inc. Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
TWI550088B (en) * 2014-01-16 2016-09-21 國立台灣大學 Method for rejuvenating aged cells and composition thereof

Also Published As

Publication number Publication date
JPH02504221A (en) 1990-12-06
AU614747B2 (en) 1991-09-12
WO1988008448A3 (en) 1988-12-01
DK521989D0 (en) 1989-10-20
EP0355112A1 (en) 1990-02-28
AU1685288A (en) 1988-12-02
FI894998A0 (en) 1989-10-20
DK521989A (en) 1989-12-05

Similar Documents

Publication Publication Date Title
AU614747B2 (en) Cell culture of anchorage dependent cells, materials and products
Yannas et al. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin
US6057148A (en) Apparatus for preparing skin cell culture
Beumer et al. Cell-seeding and in vitro biocompatibility evaluation of polymeric matrices of PEO/PBT copolymers and PLLA
US6040493A (en) Bioreactor wound dressing
EP0641223B1 (en) Biotherapeutic cell-coated microspheres
Griffith et al. Regenerative approaches as alternatives to donor allografting for restoration of corneal function
CZ187698A3 (en) Implanted hydrogel made of acrylamide copolymer for therapeutical purposes
EP1115432B1 (en) Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
JPH11503946A (en) Artificial skin containing a biocompatible substance based on a hyaluronic acid derivative as a support
EP0020753A4 (en) Skin-equivalent.
KR101508772B1 (en) Anterior ocular -associated cell sheet, three-dimensional construct and process for producing the same
KR100760989B1 (en) Method for Coculturing Fibroblasts and Keratinocytes in Biocompatible Scaffolds
Lai Influence of solvent composition on the performance of carbodiimide cross-linked gelatin carriers for retinal sheet delivery
WO1992010217A1 (en) Wound dressings and processes for manufacture thereof
JPH1147258A (en) Medical base material containing gelatin and collagen
Bisson et al. Human urothelial cells grown on collagen adsorbed to surface-modified polymers
Sipehia et al. Towards an artificial cornea: surface modifications of optically clear, oxygen permeable soft contact lens materials by ammonia plasma modification technique for the enhanced attachment and growth of corneal epithelial cells
Kitala et al. Amniotic stem cells cultured on thermoresponsive polymers allow obtaining a full cell sheet
CA2226747A1 (en) Cell culture products
KR102098691B1 (en) Hydrogels with controlled mechanical strengths and method for preparing thereof
CZ281269B6 (en) Biologically active cover of extensive areas with and process for preparing thereof
JPH1043213A (en) Manufacture of cultured skin, support and vessel used in the manufacture, and cultured skin base material and cultured skin obtained by the manufacture
CN117717650A (en) Chitosan/gelatin bulbar conjunctiva repairing biological sponge and preparation method and application thereof
EP4237538A1 (en) Methods for preservation of photosynthetically active cells and photosynthetic biomaterials

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR DK FI HU JP KP KR LK MC MG MW NO RO SD SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

CR1 Correction of entry in section i

Free format text: IN PAT.BUL.24/88,UNDER PUBLISHED REPLACE "A1" BY "A2"

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BB BG BR DK FI HU JP KP KR LK MC MG MW NO RO SD SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988903823

Country of ref document: EP

Ref document number: 894998

Country of ref document: FI

WWP Wipo information: published in national office

Ref document number: 1988903823

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988903823

Country of ref document: EP